Discontinuous peripheral enhancement of focal liver lesions on CT and MRI: outside the box of typical cavernous hemangioma.
CT
Contrast agent intravenous
Haemangioma
Hepatic infection
Hepatocellular carcinoma
Liver imaging
Liver metastases
Liver neoplasm
Magnetic resonance imaging
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
27 Aug 2024
27 Aug 2024
Historique:
received:
29
04
2024
accepted:
06
08
2024
medline:
28
8
2024
pubmed:
28
8
2024
entrez:
27
8
2024
Statut:
aheadofprint
Résumé
The discontinuous peripheral enhancement is a pattern of enhancement usually attributed to typical cavernous hemangioma, that is the most common benign solid lesion of the liver. The discontinuous peripheral enhancement, however, may be encountered in many other benign and malignant focal liver lesions as an atypical presentation or evolution, and hemangiomas with discontinuous peripheral hyperenhancement on hepatic arterial phase may not always have the typical post-contrast pattern on portal venous and delayed phases. Therefore, abdominal radiologists may be challenged in their practice by lesions with discontinuous peripheral enhancement. This pictorial essay aims to review the spectrum of benign and malignant focal liver lesions that may show discontinuous peripheral enhancement. A particular point of interest is the diagnostic tree pathway that may guide the radiologists in the differential diagnosis.
Identifiants
pubmed: 39192088
doi: 10.1007/s00261-024-04522-2
pii: 10.1007/s00261-024-04522-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Consul N, Sirlin CB, Chernyak V, Fetzer DT, Masch WR, Arora SS, et al. Imaging features at the periphery: hemodynamics, pathophysiology, and effect on LI RADS categorization. RadioGraphics 2021; 41:6, 1657-1675. https://doi.org/10.1148/rg.2021210019
doi: 10.1148/rg.2021210019
pubmed: 34559586
Yu JS, Rofsky NM. Hepatic metastases: perilesional enhancement on dynamic MRI. AJR Am J Roentgenol. 2006 Apr;186(4):1051-8. https://doi.org/10.2214/AJR.04.1698
doi: 10.2214/AJR.04.1698
pubmed: 16554578
Oto A, Kulkarni K, Nishikawa R, Baron RL. Contrast enhancement of hepatic hemangiomas on multiphase MDCT: can we diagnose hepatic hemangiomas by comparing enhancement with blood pool? AJR 2010; 195:381–386. https://doi.org/10.2214/AJR.09.3324
doi: 10.2214/AJR.09.3324
pubmed: 20651193
Caseiro-Alves F, Brito J, Araujo AE, Belo-Soares P, Rodrigues H, Cipriano A et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur Radiol (2007) 17: 1544–1554. https://doi.org/10.1007/s00330-006-0503-z
doi: 10.1007/s00330-006-0503-z
pubmed: 17260159
European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. 2016;65(2):386-398. https://doi.org/10.1016/j.jhep.2016.04.001
doi: 10.1016/j.jhep.2016.04.001
Jeong MG, Yu JS, Kim KW. Hepatic cavernous hemangioma: temporal peritumoral enhancement during multiphase dynamic MR imaging. Radiology. 2000;216(3):692-697. https://doi.org/10.1148/radiology.216.3.r00se08692
doi: 10.1148/radiology.216.3.r00se08692
pubmed: 10966696
Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000;20(2):379-397. https://doi.org/10.1148/radiographics.20.2.g00mc01379
doi: 10.1148/radiographics.20.2.g00mc01379
pubmed: 10715338
Shin N, Choi JA, Choi JM, et al. Sclerotic changes of cavernous hemangioma in the cirrhotic liver: long-term follow-up using dynamic contrast-enhanced computed tomography. Radiol Med. 2020;125(12):1225-1232. https://doi.org/10.1007/s11547-020-01221-y
doi: 10.1007/s11547-020-01221-y
pubmed: 32415477
Makhlouf HR, Ishak KG. Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: a comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis. Liver. 2002;22(1):70-78. https://doi.org/10.1046/j.0106-9543.2001.01604.x
doi: 10.1046/j.0106-9543.2001.01604.x
pubmed: 11906621
Vernuccio F, Cannella R, Porrello G, Calandra A, Midiri M, Furlan A, Brancatelli G. Uncommon imaging evolutions of focal liver lesions in cirrhosis. Abdom Radiol (NY). 2019 Sep;44(9):3069-3077. https://doi.org/10.1007/s00261-019-02101-4
doi: 10.1007/s00261-019-02101-4
pubmed: 31222462
Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology. 1994;192(2):401-406. https://doi.org/10.1148/radiology.192.2.8029404
doi: 10.1148/radiology.192.2.8029404
pubmed: 8029404
Stark DD, Felder RC, Wittenberg J, et al. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization. AJR Am J Roentgenol. 1985;145(2):213-222. https://doi.org/10.2214/ajr.145.2.213
doi: 10.2214/ajr.145.2.213
pubmed: 2992250
Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR Am J Roentgenol. 2009;193(6):W490-W496. https://doi.org/10.2214/AJR.08.1732
doi: 10.2214/AJR.08.1732
pubmed: 19933623
Nghiem HV, Bogost GA, Ryan JA, Lund P, Freeny PC, Rice KM. Cavernous hemangiomas of the liver: enlargement over time [published correction appears in AJR Am J Roentgenol 1997 Sep;169(3):919]. AJR Am J Roentgenol. 1997;169(1):137-140. https://doi.org/10.2214/ajr.169.1.9207513
doi: 10.2214/ajr.169.1.9207513
pubmed: 9207513
Ros PR, Lubbers PR, Olmsted WW, Morillo G. Hemangioma of the liver: heterogeneous appearance on T2-weighted images. AJR Am J Roentgenol. 1987;149(6):1167-1170. https://doi.org/10.2214/ajr.149.6.1167
doi: 10.2214/ajr.149.6.1167
pubmed: 3500603
Aibe H, Hondo H, Kuroiwa T, et al. Sclerosed hemangioma of the liver. Abdom Imaging. 2001;26(5):496-499. https://doi.org/10.1007/s002610000202
doi: 10.1007/s002610000202
pubmed: 11503087
Cheng HC, Tsai SH, Chiang JH, Chang CY. Hyalinized liver hemangioma mimicking malignant tumor at MR imaging. AJR Am J Roentgenol. 1995;165(4):1016-1017. https://doi.org/10.2214/ajr.165.4.7676959
doi: 10.2214/ajr.165.4.7676959
pubmed: 7676959
Miyata T, Beppu T, Kuramoto K, et al. Hepatic sclerosed hemangioma with special attention to diffusion-weighted magnetic resonance imaging. Surg Case Rep. 2018;4(1):3. https://doi.org/10.1186/s40792-017-0414-z
doi: 10.1186/s40792-017-0414-z
pubmed: 29299708
pmcid: 5752647
Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol. 2008;18(3):477-485. https://doi.org/10.1007/s00330-007-0785-9
doi: 10.1007/s00330-007-0785-9
pubmed: 17960390
Hida T, Nishie A, Tajima T, Taketomi A, Aishima S, Honda H. Sclerosed hemangioma of the liver: possible diagnostic value of diffusion-weighted magnetic resonance imaging. Jpn J Radiol. 2010;28(3):235-238. https://doi.org/10.1007/s11604-009-0407-3
doi: 10.1007/s11604-009-0407-3
pubmed: 20437137
Doyle DJ, Khalili K, Guindi M, Atri M. Imaging features of sclerosed hemangioma. AJR Am J Roentgenol. 2007;189(1):67-72. https://doi.org/10.2214/AJR.06.1076
doi: 10.2214/AJR.06.1076
pubmed: 17579154
Nonomura A, Mizukami Y, Kadoya M. Angiomyolipoma of the liver: a collective review. J Gastroenterol. 1994;29(1):95-105. https://doi.org/10.1007/BF01229084
doi: 10.1007/BF01229084
pubmed: 8199705
Fricke BL, Donnelly LF, Casper KA, Bissler JJ. Frequency and imaging appearance of hepatic angiomyolipomas in pediatric and adult patients with tuberous sclerosis. AJR Am J Roentgenol. 2004;182(4):1027-1030. https://doi.org/10.2214/ajr.182.4.1821027
doi: 10.2214/ajr.182.4.1821027
pubmed: 15039181
Cai PQ, Wu YP, Xie CM, Zhang WD, Han R, Wu PH. Hepatic angiomyolipoma: CT and MR imaging findings with clinical-pathologic comparison. Abdom Imaging. 2013;38(3):482-489. https://doi.org/10.1007/s00261-012-9932-0
doi: 10.1007/s00261-012-9932-0
pubmed: 22996326
Yan F, Zeng M, Zhou K, et al. Hepatic angiomyolipoma: various appearances on two-phase contrast scanning of spiral CT. Eur J Radiol. 2002;41(1):12-18. https://doi.org/10.1016/s0720-048x(01)00392-8
doi: 10.1016/s0720-048x(01)00392-8
pubmed: 11750147
Krebs S, Esposito I, Lersch C, Gaa J, Schmid RM, Ebert O. Preoperative radiological characterization of hepatic angiomyolipoma using magnetic resonance imaging and contrast-enhanced ultrasonography: a case report. J Med Case Rep. 2011;5:481. https://doi.org/10.1186/1752-1947-5-481
doi: 10.1186/1752-1947-5-481
pubmed: 21943146
pmcid: 3189154
Sakamoto Y, Inoue K, Ohtomo K, Mori M, Makuuchi M. Magnetic resonance imaging of an angiomyolipoma of the liver. Abdom Imaging. 1998;23(2):158-160. https://doi.org/10.1007/s002619900311
doi: 10.1007/s002619900311
pubmed: 9516505
Jeon TY, Kim SH, Lim HK, Lee WJ. Assessment of triple-phase CT findings for the differentiation of fat-deficient hepatic angiomyolipoma from hepatocellular carcinoma in non-cirrhotic liver. Eur J Radiol. 2010;73(3):601-606. https://doi.org/10.1016/j.ejrad.2009.01.010
doi: 10.1016/j.ejrad.2009.01.010
pubmed: 19200676
Ahmadi T, Itai Y, Takahashi M, et al. Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging. 1998;23(5):520-526. https://doi.org/10.1007/s002619900391
doi: 10.1007/s002619900391
pubmed: 9841067
Lee SJ, Kim SY, Kim KW, et al. Hepatic angiomyolipoma versus hepatocellular carcinoma in the noncirrhotic liver on gadoxetic acid-enhanced MRI: a diagnostic challenge. AJR Am J Roentgenol. 2016;207(3):562-570. https://doi.org/10.2214/AJR.15.15602
doi: 10.2214/AJR.15.15602
pubmed: 27248975
Kim R, Lee JM, Joo I, et al. Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Abdom Imaging. 2015;40(3):531-541. https://doi.org/10.1007/s00261-014-0244-4
doi: 10.1007/s00261-014-0244-4
pubmed: 25231411
Ren N, Qin LX, Tang ZY, Wu ZQ, Fan J. Diagnosis and treatment of hepatic angiomyolipoma in 26 cases. World J Gastroenterol. 2003;9(8):1856-1858. https://doi.org/10.3748/wjg.v9.i8.1856
doi: 10.3748/wjg.v9.i8.1856
pubmed: 12918138
pmcid: 4611561
Klompenhouwer AJ, Dwarkasing RS, Doukas M, et al. Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome. HPB (Oxford). 2020;22(4):622-629. https://doi.org/10.1016/j.hpb.2019.09.004
doi: 10.1016/j.hpb.2019.09.004
pubmed: 31619346
Klompenhouwer AJ, Verver D, Janki S, et al. Management of hepatic angiomyolipoma: A systematic review. Liver Int. 2017;37(9):1272-1280. https://doi.org/10.1111/liv.13381
doi: 10.1111/liv.13381
pubmed: 28177188
Garoufalia Z, Machairas N, Kostakis ID, et al. Malignant potential of epithelioid angiomyolipomas of the liver: A case report and comprehensive review of the literature. Mol Clin Oncol. 2018;9(2):226-230. https://doi.org/10.3892/mco.2018.1659
doi: 10.3892/mco.2018.1659
pubmed: 30101028
pmcid: 6083421
ZAK FG. Peliosis hepatis. Am J Pathol. 1950;26(1):1-15
Choi HH, Manning MA, Mehrotra AK, Wagner S, Jha RC. Primary hepatic neoplasms of vascular origin: key imaging features and differential diagnoses with radiology-pathology correlation. AJR Am J Roentgenol. 2017;209(6):W350-W359. https://doi.org/10.2214/AJR.17.18100
doi: 10.2214/AJR.17.18100
pubmed: 29023152
Iannaccone R, Federle MP, Brancatelli G, et al. Peliosis hepatis: spectrum of imaging findings. AJR Am J Roentgenol. 2006;187(1):W43-W52. https://doi.org/10.2214/AJR.05.0167
doi: 10.2214/AJR.05.0167
pubmed: 16794138
Gouya H, Vignaux O, Legmann P, de Pigneux G, Bonnin A. Peliosis hepatis: triphasic helical CT and dynamic MRI findings. Abdom Imaging. 2001;26(5):507-509. https://doi.org/10.1007/s00261-001-0023-x
doi: 10.1007/s00261-001-0023-x
pubmed: 11503089
Yoshida M, Utsunomiya D, Takada S, et al. The imaging findings of Peliosis hepatis on gadoxetic acid enhanced MRI. Radiol Case Rep. 2020;15(8):1261-1265. https://doi.org/10.1016/j.radcr.2020.04.059
doi: 10.1016/j.radcr.2020.04.059
pubmed: 32577143
pmcid: 7303918
Elsayes KM, Shaaban AM, Rothan SM, et al. A comprehensive approach to hepatic vascular disease. Radiographics. 2017;37(3):813-836. https://doi.org/10.1148/rg.2017160161
doi: 10.1148/rg.2017160161
pubmed: 28430541
Mortelé KJ, Segatto E, Ros PR. The infected liver: radiologic-pathologic correlation.Radiographics. 2004;24(4):937-955. https://doi.org/10.1148/rg.244035719
doi: 10.1148/rg.244035719
pubmed: 15256619
Shi SH, Zhai ZL, Zheng SS. Pyogenic liver abscess of biliary origin: the existing problems and their strategies. Semin Liver Dis. 2018;38(3):270-283. https://doi.org/10.1055/s-0038-1661363
doi: 10.1055/s-0038-1661363
pubmed: 30041279
Malekzadeh S, Widmer L, Salahshour F, Egger B, Ronot M, Thoeny HC. Typical imaging finding of hepatic infections: a pictorial essay. Abdom Radiol (NY). 2021;46(2):544-561. https://doi.org/10.1007/s00261-020-02642-z
doi: 10.1007/s00261-020-02642-z
pubmed: 32715334
Bächler P, Baladron MJ, Menias C, et al. Multimodality Imaging of Liver Infections: Differential Diagnosis and Potential Pitfalls. Radiographics. 2016;36(4):1001-1023. https://doi.org/10.1148/rg.2016150196
doi: 10.1148/rg.2016150196
pubmed: 27232504
Mathieu D, Vasile N, Fagniez PL, Segui S, Grably D, Lardé D. Dynamic CT features of hepatic abscesses. Radiology. 1985;154(3):749-752. https://doi.org/10.1148/radiology.154.3.3969480
doi: 10.1148/radiology.154.3.3969480
pubmed: 3969480
Ishak KG, Sesterhenn IA, Goodman ZD, Rabin L, Stromeyer FW. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol. 1984;15(9):839-852. https://doi.org/10.1016/s0046-8177(84)80145-8
doi: 10.1016/s0046-8177(84)80145-8
pubmed: 6088383
Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer. 1999;85(3):562-582. https://doi.org/10.1002/(sici)1097-0142(19990201)85:3<562::aid-cncr7>3.0.co;2-t
doi: 10.1002/(sici)1097-0142(19990201)85:3<562::aid-cncr7>3.0.co;2-t
pubmed: 10091730
Miller WJ, Dodd GD 3rd, Federle MP, Baron RL. Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol. 1992;159(1):53-57. https://doi.org/10.2214/ajr.159.1.1302463
doi: 10.2214/ajr.159.1.1302463
pubmed: 1302463
Zhou L, Cui MY, Xiong J, et al. Spectrum of appearances on CT and MRI of hepatic epithelioid hemangioendothelioma. BMC Gastroenterol. 2015;15:69. https://doi.org/10.1186/s12876-015-0299-x
doi: 10.1186/s12876-015-0299-x
pubmed: 26088585
pmcid: 4474347
Bruegel M, Muenzel D, Waldt S, Specht K, Rummeny EJ. Hepatic epithelioid hemangioendothelioma: findings at CT and MRI including preliminary observations at diffusion-weighted echo-planar imaging. Abdom Imaging. 2011;36(4):415-424. https://doi.org/10.1007/s00261-010-9641-5
doi: 10.1007/s00261-010-9641-5
pubmed: 20730424
Luo L, Cai Z, Zeng S, et al. CT and MRI features of hepatic epithelioid haemangioendothelioma: a multi-institutional retrospective analysis of 15 cases and a literature review. Insights Imaging. 2023;14(1):2. https://doi.org/10.1186/s13244-022-01344-y
doi: 10.1186/s13244-022-01344-y
pubmed: 36600110
pmcid: 9813315
Alomari AI. The lollipop sign: a new cross-sectional sign of hepatic epithelioid hemangioendothelioma. Eur J Radiol. 2006;59(3):460-464. https://doi.org/10.1016/j.ejrad.2006.03.022
doi: 10.1016/j.ejrad.2006.03.022
pubmed: 16644166
Paolantonio P, Laghi A, Vanzulli A, et al. MRI of hepatic epithelioid hemangioendothelioma (HEH). J Magn Reson Imaging. 2014;40(3):552-558. https://doi.org/10.1002/jmri.24391
doi: 10.1002/jmri.24391
pubmed: 24677597
Mehrabi A, Kashfi A, Fonouni H, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer. 2006;107(9):2108-2121. https://doi.org/10.1002/cncr.22225
doi: 10.1002/cncr.22225
pubmed: 17019735
Koch M, Nielsen GP, Yoon SS. Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangioperictyomas. J Surg Oncol. 2008;97(4):321-329. https://doi.org/10.1002/jso.20973
doi: 10.1002/jso.20973
pubmed: 18286475
Koyama T, Fletcher JG, Johnson CD, Kuo MS, Notohara K, Burgart LJ. Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology. 2002;222(3):667-673. https://doi.org/10.1148/radiol.2223010877
doi: 10.1148/radiol.2223010877
pubmed: 11867783
Peterson MS, Baron RL, Rankin SC. Hepatic angiosarcoma: findings on multiphasic contrast-enhanced helical CT do not mimic hepatic hemangioma. AJR Am J Roentgenol. 2000;175(1):165-170. https://doi.org/10.2214/ajr.175.1.1750165
doi: 10.2214/ajr.175.1.1750165
pubmed: 10882268
Pickhardt PJ, Kitchin D, Lubner MG, Ganeshan DM, Bhalla S, Covey AM. Primary hepatic angiosarcoma: multi-institutional comprehensive cancer centre review of multiphasic CT and MR imaging in 35 patients. Eur Radiol. 2015;25(2):315-322. https://doi.org/10.1007/s00330-014-3442-0
doi: 10.1007/s00330-014-3442-0
pubmed: 25278246
Bruegel M, Muenzel D, Waldt S, Specht K, Rummeny EJ. Hepatic angiosarcoma: cross-sectional imaging findings in seven patients with emphasis on dynamic contrast-enhanced and diffusion-weighted MRI. Abdom Imaging. 2013;38(4):745-754. https://doi.org/10.1007/s00261-012-9967-2
doi: 10.1007/s00261-012-9967-2
pubmed: 23223833
Chung YE, Kim MJ, Park YN, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29(3):683-700. https://doi.org/10.1148/rg.293085729
doi: 10.1148/rg.293085729
pubmed: 19448110
Lacomis JM, Baron RL, Oliver JH 3rd, Nalesnik MA, Federle MP. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology. 1997;203(1):98-104. https://doi.org/10.1148/radiology.203.1.9122423
doi: 10.1148/radiology.203.1.9122423
pubmed: 9122423
Kim TK, Choi BI, Han JK, Jang HJ, Cho SG, Han MC. Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings. Radiology. 1997;204(2):539-543. https://doi.org/10.1148/radiology.204.2.9240550
doi: 10.1148/radiology.204.2.9240550
pubmed: 9240550
Kim SA, Lee JM, Lee KB, et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology. 2011;260(1):148-157. https://doi.org/10.1148/radiol.11101777
doi: 10.1148/radiol.11101777
pubmed: 21474703
Valls C, Gumà A, Puig I, et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging. 2000;25(5):490-496. https://doi.org/10.1007/s002610000079
doi: 10.1007/s002610000079
pubmed: 10931983
Asayama Y, Yoshimitsu K, Irie H, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology. 2006;238(1):150-155. https://doi.org/10.1148/radiol.2381041765
doi: 10.1148/radiol.2381041765
pubmed: 16304089
Kang Y, Lee JM, Kim SH, Han JK, Choi BI. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology. 2012;264(3):751-760. https://doi.org/10.1148/radiol.12112308
doi: 10.1148/radiol.12112308
pubmed: 22798225
Koh J, Chung YE, Nahm JH, et al. Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI. Eur Radiol. 2016;26(2):407-416. https://doi.org/10.1007/s00330-015-3846-5
doi: 10.1007/s00330-015-3846-5
pubmed: 26002136
Cannella R, Cunha GM, Catania R, Chupetlovska K, Borhani AA, Fowler KJ, Furlan A. Magnetic resonance imaging of nonhepatocellular malignancies in chronic liver disease. Magn Reson Imaging Clin N Am. 2021 Aug;29(3):404-418. https://doi.org/10.1016/j.mric.2021.05.009
doi: 10.1016/j.mric.2021.05.009
pubmed: 34243926
Vernuccio F, Gagliano DS, Cannella R, Ba-Ssalamah A, Tang A, Brancatelli G. Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting. Insights Imaging. 2021;12(1):8. https://doi.org/10.1186/s13244-020-00928-w
doi: 10.1186/s13244-020-00928-w
pubmed: 33432491
pmcid: 7801550
Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol. 2013;201(4):W603-W611. https://doi.org/10.2214/AJR.12.10262
doi: 10.2214/AJR.12.10262
pubmed: 24059399
Min JH, Kim YK, Choi SY, et al. Intrahepatic mass-forming cholangiocarcinoma: arterial enhancement patterns at MRI and prognosis. Radiology. 2019;290(3):691-699. https://doi.org/10.1148/radiol.2018181485
doi: 10.1148/radiol.2018181485
pubmed: 30620253
Nanashima A, Sumida Y, Abo T, Oikawa M, Murakami G, Takeshita H, Fukuoka H, Hidaka S, Nagayasu T, Sakamoto I, Sawai T. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol 2008;98:535-9. https://doi.org/10.1002/jso.21142
doi: 10.1002/jso.21142
pubmed: 18814285
Vilana R, Forner A, Bianchi L, et al. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology. 2010;51(6):2020-2029. https://doi.org/10.1002/hep.23600
doi: 10.1002/hep.23600
pubmed: 20512990
Xu J, Igarashi S, Sasaki M, et al. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int. 2012;32(7):1156-1164. https://doi.org/10.1111/j.1478-3231.2012.02783.x
doi: 10.1111/j.1478-3231.2012.02783.x
pubmed: 22417172
Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom Radiol (NY). 2018;43(1):149-157. https://doi.org/10.1007/s00261-017-1196-2
doi: 10.1007/s00261-017-1196-2
pubmed: 28580538
Kim MY, Joo I, Kang HJ, Bae JS, Jeon SK, Lee JM. LI-RADS M (LR-M) criteria and reporting algorithm of v2018: diagnostic values in the assessment of primary liver cancers on gadoxetic acid-enhanced MRI. Abdom Radiol (NY). 2020;45(8):2440-2448. https://doi.org/10.1007/s00261-020-02545-z
doi: 10.1007/s00261-020-02545-z
pubmed: 32382817
Jiang H, Song B, Qin Y, et al. Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features. Eur Radiol. 2021;31(6):3638-3648. https://doi.org/10.1007/s00330-020-07488-z
doi: 10.1007/s00330-020-07488-z
pubmed: 33245494